ExodusPoint Capital Management, LP

Position in GERN — Geron Corp

CIK 1736225 NEW YORK, NY

Position in GERN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,233,465

+$3,215,605 QoQ

Shares Held

2,526,145

+20974.0% QoQ

Ownership

0.393%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#33

of 258 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names. GERN ranks #27 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	249,259	$21,234,374
2	BBIO	BridgeBio Pharma, Inc.	224,927	$16,752,562
3	ORKA	Oruka Therapeutics, Inc.	148,212	$14,105,336
4	VKTX	Viking Therapeutics, Inc.	361,126	$14,087,525
5	JAZZ	Jazz Pharmaceuticals plc	53,201	$12,819,844
6	NAMS	NewAmsterdam Pharma Co N.V.	304,334	$10,313,879
7	TGTX	Tg Therapeutics, Inc.	164,513	$9,038,344
8	DNLI	Denali Therapeutics Inc.	336,567	$8,656,503

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,233,465	2,526,145	+20974.0%	Shares	Sole	2026-08-14
2026-03-31	$17,860	11,987	-74.5%	Shares	Sole	2026-05-14
2025-09-30	$64,437	47,035	-55.8%	Shares	Sole	2025-11-14
2024-12-31	$376,801	106,441	-17.1%	Shares	Sole	2025-02-12
2023-09-30	$272,280	128,434	-4.5%	Shares	Sole	2023-11-13
2022-12-31	$325,577	134,536	+272.4%	Shares	Sole	2023-02-13
2022-06-30	$56,001	36,130	-61.4%	Shares	Sole	2022-08-22
2021-12-31	$114,106	93,530	+2.8%	Shares	Sole	2022-02-11
2021-09-30	$124,597	90,947	+37.7%	Shares	Sole	2021-11-15
2021-06-30	$93,102	66,030	+26.4%	Shares	Sole	2021-08-16
2021-03-31	$82,523	52,230	+9.0%	Shares	Sole	2021-05-17
2020-12-31	$76,208	47,930	+48.7%	Shares	Sole	2021-02-16
2020-09-30	$56,101	32,242	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.